Brad Barnett
Chief Tech/Sci/R&D Officer at COGENT BIOSCIENCES, INC.
Brad Barnett active positions
| Companies | Position | Start | End |
|---|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - | - |
Career history of Brad Barnett
Former positions of Brad Barnett
| Companies | Position | Start | End |
|---|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 2015-02-28 | 2019-07-31 |
Training of Brad Barnett
| Colorado State University | Undergraduate Degree |
| The University of Colorado | Masters Business Admin |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Brad Barnett
- Experience
